Lets wait for the conference call to clear up several issues. At least some revenue and deals pending so it shows progress. Its all about the management team, products and confirmation of potential vaccines. The hype is gone for now and not being listed doesn't help either. Of course we have had positive surprises in the past 8 months but not all promised/projected results. At the end of the day its a high risk investment and nobody has the answer if the company will be successful but ........I think its worth the risk for now !!
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links